鼓膜置管联合腺样体切除对分泌性中耳炎临床疗效分析

目的针对耳内窥镜下鼓膜置管联合鼻内镜下腺样体切除对分泌性中耳炎患者听觉、术后感染及临床疗效的影响进行分析研究。方法选择2012年2月至2015年2月期间收治的160例分泌性中耳炎患者，分为对照组和观察组，每组各80例。对照组实施耳内窥镜下鼓膜置管引流治疗，观察组实施耳内窥镜下鼓膜置管联合鼻内镜下腺样体切除治疗，对两组患者的治疗有效率以及术后产生的并发症等指标进行观察比较。结果观察组与对照组患者临床治疗总有效率为97．50％、81．25％，差异有统计学意义（P〈O．05）。观察组与对照组患者的并发症发生率为6．25％、27．50％，差异有统计学意义（P〈O．05）。观察组与对照组患者听力不全发生率为1．25％、8．75％，差异有统计学意义（P〈O．05）。观察组与对照组患者术后感染发生率为1．25％、10．00％，差异有统计学意义（P〈O．05）。观察组与对照组患者的复发率为0．00％、5．00％，差异有统计学意义（P〈O．05）。结论在分泌性中耳炎患者的治疗中，对其实施耳内窥镜下鼓膜置管联合鼻内镜下腺样体切除治疗，可以提高患者的临床治疗效果，降低并发症的产生，并有效的预防病情的复发，降低术后感染、听觉障碍的发生率，所以可以将耳内窥镜下鼓膜置管联合鼻内镜下腺样体切除治疗，在临床上进行推广应用。

Objective To analyze the influence of hearing, postoperative infection and clinical efficacy in patients with secretory otitis media by tympanostomy tube insertion combined with adenoidectomy under the ear and nasal endoscopy. Methods 160 patients with secretory otitis media were randomly divided into control group and observation group （ from February 2012 to February 2015 ） , 80 cases in each group. In the control group, patients were treated with tympanostomy tube insertion by ear endoscopy.In the observation group, patients were treated with tympanostomy tube insertion combined with adenoidectomy under the ear and nasal endoscopy, the treatment efficiency and postoperative complications were observed and compared of two groups. Results The total effective rate of the observation group and the control group was 97.50% and 81.25%, the difference was statistically significant （ P〈0.05 ） . The incidence of complications in the observation group and the control group was 6.25% and 27.50%, the difference was statistically significant （ P〈0.05 ） . In the observation group and the control group, the incidence of incomplete hearing was 1.25% and 8.75%, the difference was statistically significant （P〈0.05） . The incidence rate of postoperative infection in the observation group and the control group was 1.25% and 10%, the difference was statistically significant （ P〈0.05 ） . The recurrence rate of the observation group and the control group were 0% and 5%, the difference was statistically significant （ P〈0.05 ） . Conclusion The treatment of patients with secretory otitis media in its tympanostomy tube insertion combined with adenoidectomy under the ear and nasal endoscopy, can improve the clinical efficacy and reduce complications, and effectively prevent the recurrence, reduce the postoperative infection and the incidence of hearing impairment.So tympanostomy tube insertion combined with adenoidectomy under the ear and nasal endoscopy can be performed in clinical application.